Hemophagocytic Lymphohistiocytosis Associated with Malignancies and with Epstein-Barr Virus

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-319-59632-7_12
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinicopathological categorization of Epstein–Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications

  2017cited by this paper
• Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.

  2016cited by this paper
• Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.

  2016cited by this paper
• Therapeutic effect of JAK1/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice.

  2016cited by this paper
• Lymphoproliferative Disease, X-Linked

  2016cited by this paper
• Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years

  2016cited by this paper
• Maude SL, Teachey DT, Porter DL, Grupp SA. CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia. Blood. 2015;125(26):4017-4023.

  2016cited by this paper
• Cytotoxic granule secretion by lymphocytes and its link to immune homeostasis

  2015cited by this paper
• The significance of pre-therapeutic F-18-FDG PET–CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable

  2015cited by this paper
• Primary Immunodeficiencies Associated with EBV Disease.

  2015cited by this paper
• Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis.

  2015cited by this paper
• STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas

  2015cited by this paper
• Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis

  2015cited by this paper
• Acute kidney injury in adults with hemophagocytic lymphohistiocytosis.

  2015cited by this paper
• Malignancy‐associated haemophagocytic lymphohistiocytosis in children and adolescents

  2015cited by this paper
• Cancer risk in relatives of patients with a primary disorder of lymphocyte cytotoxicity: a retrospective cohort study.

  2015cited by this paper
• Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide

  2015cited by this paper
• Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies

  2015cited by this paper
• Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis

  2014cited by this paper
• Hemophagocytic Lymphohistiocytosis

  2014cited by this paper
• Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome

  2014cited by this paper
• Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.

  2014cited by this paper
• Prognostic factors of Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in children: Report of the Japan Histiocytosis Study Group

  2014cited by this paper
• Reactive hemophagocytic syndrome in adults: A multicenter retrospective analysis of 162 patients

  2014cited by this paper
• Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.

  2014cited by this paper
• Adult haemophagocytic syndrome.

  2014cited by this paper
• Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party

  2014cited by this paper
• Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy

  2014cited by this paper
• Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis

  2014cited by this paper
• Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis.

  2014cited by this paper
• Clinical characteristics and outcomes of chédiak–Higashi syndrome: A nationwide survey of Japan

  2013cited by this paper
• EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood

  2013cited by this paper
• A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome

  2013cited by this paper
• Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution

  2013cited by this paper
• Primary immunodeficiencies predisposed to Epstein‐Barr virus‐driven haematological diseases

  2013cited by this paper
• Occurrence of Nodular Lymphocyte-Predominant Hodgkin Lymphoma in Hermansky-Pudlak Type 2 Syndrome Is Associated to Natural Killer and Natural Killer T Cell Defects

  2013cited by this paper
• Human perforin mutations and susceptibility to multiple primary cancers

  2013cited by this paper
• Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment.

  2013cited by this paper
• X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.

  2013cited by this paper
• Treatment of Epstein Barr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens

  2013cited by this paper
• Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis

  2013cited by this paper
• Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis.

  2013cited by this paper
• Development of classical Hodgkin’s lymphoma in an adult with biallelic STXBP2 mutations

  2013cited by this paper
• Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan

  2013cited by this paper
• Treatment choice of immunotherapy or further chemotherapy for Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis

  2012cited by this paper
• Risk factors for early death in children with haemophagocytic lymphohistiocytosis

  2012cited by this paper
• Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).

  2012cited by this paper
• A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.

  2012cited by this paper
• Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis

  2012cited by this paper
• Reduced‐intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis

  2012cited by this paper
• EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

  2012cited by this paper
• Cyclosporine A for Chemotherapy-Resistant Subcutaneous Panniculitis-Like T Cell Lymphoma with Hemophagocytic Syndrome

  2011cited by this paper
• Hemophagocytic lymphohistiocytosis associated with precursor B acute lymphoblastic leukemia

  2011cited by this paper
• Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis.

  2011cited by this paper
• X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.

  2011cited by this paper
• Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in Japan

  2010cited by this paper
• Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis

  2010cited by this paper
• Critical care management of patients with hemophagocytic lymphohistiocytosis

  2010cited by this paper
• Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.

  2010cited by this paper
• Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

  2010cited by this paper
• Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overview

  2010cited by this paper
• Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.

  2009cited by this paper
• The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease

  2009cited by this paper
• Sequential transplants for respective relapse of Hodgkin disease and hemophagocytic lymphohistiocytosis: a treatment dilemma.

  2009cited by this paper
• Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer

  2009cited by this paper
• Infection of T lymphocytes in Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis in children of non‐Asian origin

  2009cited by this paper
• Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.

  2009cited by this paper
• Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus.

  2008cited by this paper
• The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus‐associated multi‐centric Castleman's disease

  2008cited by this paper
• Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children

  2008cited by this paper
• The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis

  2008cited by this paper
• Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: Comparison of T-cell lymphoma with and without hemophagocytic syndrome

  2008cited by this paper
• Nationwide Survey of Hemophagocytic Lymphohistiocytosis in Japan

  2007cited by this paper
• Immunophenotypic analysis of Epstein–Barr virus (EBV)‐infected CD8+ T cells in a patient with EBV‐associated hemophagocytic lymphohistiocytosis

  2007cited by this paper
• Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.

  2007cited by this paper
• Association of transforming growth factor-β1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases

  2007cited by this paper
• Cytokine production by hepatic anaplastic large-cell lymphoma presenting as a rheumatic syndrome.

  2007cited by this paper
• HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis

  2007cited by this paper
• Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome

  2007cited by this paper
• Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.

  2006cited by this paper
• Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group

  2006cited by this paper
• Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.

  2005cited by this paper
• REGIONAL DIFFERENCES IN THE EPIDEMIOLOGY OF INVASIVE PNEUMOCOCCAL DISEASE IN TODDLERS IN GERMANY

  2005cited by this paper
• SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.

  2005cited by this paper
• A single amino acid change A91V in perforin: a novel, frequent predisposing factor to childhood acute lymphoblastic leukemia?

  2005cited by this paper
• Virological aspects of Epstein-Barr virus infections.

  2005cited by this paper
• Histiocytosis following T-acute lymphoblastic leukemia: A BFM study

  2005cited by this paper
• Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences.

  2005cited by this paper
• Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.

  2004cited by this paper
• Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis‐like T‐cell lymphoma

  2004cited by this paper
• A proportion of patients with lymphoma may harbor mutations of the perforin gene.

  2004cited by this paper
• Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

  2004cited by this paper
• Epstein-Barr Virus Latent Membrane Protein-1 Mediates Upregulation of Tumor Necrosis Factor-α in EBV-Infected T Cells: Implications for the Pathogenesis of Hemophagocytic Syndrome

  2003cited by this paper
• Acquisition of Viral Receptor by NK Cells Through Immunological Synapse1

  2003cited by this paper
• Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

  2002cited by this paper
• Viral Load in Epstein‐Barr Virus‐Associated Hemophagocytic Syndrome

  2002cited by this paper
• Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.

  2001cited by this paper
• Familial Hemophagocytic Lymphohistiocytosis: Too Little Cell Death Can Seriously Damage Your Health

  2001cited by this paper
• The immunological synapse of CTL contains a secretory domain and membrane bridges.

  2001cited by this paper
• Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

  2001cited by this paper

• [Sucecesfull bone marrow transplantation in a case of familial hemophagocytic lymphohistiocytosis type 3].

  2021cites this paper
• Hemophagocytic lymphohistiocytosis — what's new in old diagnostic and clinical criteria?

  2021cites this paper